These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
356 related articles for article (PubMed ID: 17118749)
1. BMP stimulation of alkaline phosphatase activity in pluripotent mouse C2C12 cells is inhibited by dermatopontin, one of the most abundant low molecular weight proteins in demineralized bone matrix. Behnam K; Murray SS; Brochmann EJ Connect Tissue Res; 2006; 47(5):271-7. PubMed ID: 17118749 [TBL] [Abstract][Full Text] [Related]
2. The effect of crosslinking heparin to demineralized bone matrix on mechanical strength and specific binding to human bone morphogenetic protein-2. Lin H; Zhao Y; Sun W; Chen B; Zhang J; Zhao W; Xiao Z; Dai J Biomaterials; 2008 Mar; 29(9):1189-97. PubMed ID: 18083224 [TBL] [Abstract][Full Text] [Related]
3. Changes in secreted and cell associated proteoglycan synthesis during conversion of myoblasts to osteoblasts in response to bone morphogenetic protein-2: role of decorin in cell response to BMP-2. Gutierrez J; Osses N; Brandan E J Cell Physiol; 2006 Jan; 206(1):58-67. PubMed ID: 15920756 [TBL] [Abstract][Full Text] [Related]
4. Heparin inhibits BMP-2 osteogenic bioactivity by binding to both BMP-2 and BMP receptor. Kanzaki S; Takahashi T; Kanno T; Ariyoshi W; Shinmyouzu K; Tujisawa T; Nishihara T J Cell Physiol; 2008 Sep; 216(3):844-50. PubMed ID: 18449905 [TBL] [Abstract][Full Text] [Related]
5. Activation of demineralized bone matrix by genetically engineered human bone morphogenetic protein-2 with a collagen binding domain derived from von Willebrand factor propolypeptide. Chen B; Lin H; Zhao Y; Wang B; Zhao Y; Liu Y; Liu Z; Dai J J Biomed Mater Res A; 2007 Feb; 80(2):428-34. PubMed ID: 17013862 [TBL] [Abstract][Full Text] [Related]
6. Quantitative and sensitive in vitro assay for osteoinductive activity of demineralized bone matrix. Han B; Tang B; Nimni ME J Orthop Res; 2003 Jul; 21(4):648-54. PubMed ID: 12798064 [TBL] [Abstract][Full Text] [Related]
8. Enhancement of bone morphogenetic protein-2 expression and bone formation by coumarin derivatives via p38 and ERK-dependent pathway in osteoblasts. Tang CH; Yang RS; Chien MY; Chen CC; Fu WM Eur J Pharmacol; 2008 Jan; 579(1-3):40-9. PubMed ID: 17980360 [TBL] [Abstract][Full Text] [Related]
9. Responsiveness of clonal limb bud cell lines to bone morphogenetic protein 2 reveals a sequential relationship between cartilage and bone cell phenotypes. Rosen V; Nove J; Song JJ; Thies RS; Cox K; Wozney JM J Bone Miner Res; 1994 Nov; 9(11):1759-68. PubMed ID: 7532346 [TBL] [Abstract][Full Text] [Related]
10. Intervariability and intravariability of bone morphogenetic proteins in commercially available demineralized bone matrix products. Bae HW; Zhao L; Kanim LE; Wong P; Delamarter RB; Dawson EG Spine (Phila Pa 1976); 2006 May; 31(12):1299-306; discussion 1307-8. PubMed ID: 16721289 [TBL] [Abstract][Full Text] [Related]
11. Deletion mutants of BMP folding variants act as BMP antagonists and are efficient inhibitors for heterotopic ossification. Weber FE; Schmökel H; Oelgeschläger M; Nickel J; Maly FE; Hortschansky P; Grätz KW J Bone Miner Res; 2003 Dec; 18(12):2142-51. PubMed ID: 14672349 [TBL] [Abstract][Full Text] [Related]
12. Enhanced bioactivity of bone morphogenetic protein-2 with low dose of 2-N, 6-O-sulfated chitosan in vitro and in vivo. Zhou H; Qian J; Wang J; Yao W; Liu C; Chen J; Cao X Biomaterials; 2009 Mar; 30(9):1715-24. PubMed ID: 19131102 [TBL] [Abstract][Full Text] [Related]
13. Carrier dependent cell differentiation of bone morphogenetic protein-2 induced osteogenesis and chondrogenesis during the early implantation stage in rats. Takita H; Vehof JW; Jansen JA; Yamamoto M; Tabata Y; Tamura M; Kuboki Y J Biomed Mater Res A; 2004 Oct; 71(1):181-9. PubMed ID: 15368268 [TBL] [Abstract][Full Text] [Related]
14. Effects of growth factors on cell migration and alkaline phosphatase release. Gonnerman KN; Brown LS; Chu TM Biomed Sci Instrum; 2006; 42():60-5. PubMed ID: 16817586 [TBL] [Abstract][Full Text] [Related]
15. BMP-2 regulation of PTHrP and osteoclastogenic factors during osteoblast differentiation of C2C12 cells. Susperregui AR; Viñals F; Ho PW; Gillespie MT; Martin TJ; Ventura F J Cell Physiol; 2008 Jul; 216(1):144-52. PubMed ID: 18247361 [TBL] [Abstract][Full Text] [Related]
16. Osteoinductivity of partially purified bovine, ostrich and emu bone morphogenetic proteins in vitro. Hu Z; Peel SA; Lindholm TC; Sàndor GK; Clokie CM; Su Y J Biomed Mater Res A; 2011 Sep; 98(3):473-7. PubMed ID: 21630431 [TBL] [Abstract][Full Text] [Related]
17. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway. Yamashita M; Otsuka F; Mukai T; Otani H; Inagaki K; Miyoshi T; Goto J; Yamamura M; Makino H J Endocrinol; 2008 Mar; 196(3):601-13. PubMed ID: 18310456 [TBL] [Abstract][Full Text] [Related]
18. Multidomain synthetic peptide B2A2 synergistically enhances BMP-2 in vitro. Lin X; Zamora PO; Albright S; Glass JD; Peña LA J Bone Miner Res; 2005 Apr; 20(4):693-703. PubMed ID: 15765189 [TBL] [Abstract][Full Text] [Related]
19. Uptake of nickel from 316L stainless steel into contacting osteoblastic cells and metal ion interference with BMP-2-induced alkaline phosphatase. Mölders M; Felix J; Bingmann D; Hirner A; Wiemann M J Biomed Mater Res A; 2007 Nov; 83(2):303-12. PubMed ID: 17437303 [TBL] [Abstract][Full Text] [Related]
20. Assay of bone morphogenetic protein-2, -4, and -7 in human demineralized bone matrix. Pietrzak WS; Woodell-May J; McDonald N J Craniofac Surg; 2006 Jan; 17(1):84-90. PubMed ID: 16432413 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]